Heartburn Drug Lawsuits Centralized in MDL. August 4, 2017 — The U.S. Judicial Panel on Multidistrict Litigation (JPML) has centralized 161 lawsuits involving kidney injuries from heartburn drugs like Nexium and Prilosec into one federal court. The lawsuits will be coordinated in Multi-District Litigation (MDL No. 2798) under Judge Claire C. Cecchi in the District of New Jersey — In RE.

The Judicial Panel on Centralized Litigation (JPML) has determined that the size and scope of PPI lawsuits against the makers of Nexium, Prilosec, Prevacid, Protonix, and other proton pump inhibitors (PPIs) qualifies the litigation for centralization before one New Jersey federal judge for coordinated pretrial proceedings.

PPIs are amongst the most commonly prescribed drug in the United States. In 2009, they generated 13.9 Billion dollars and were the 3rd largest class of drug in the country. In 2009, they generated 13.9 Billion dollars and were the 3rd largest class of drug in the country.

On Monday, May 23, 2011, the U.S. Judicial Panel on Multidistrict Litigation (JPML) ordered that all Fosamax femur fracture lawsuits filed in federal court be transferred to Honorable Garrett E. Brown, Jr., in the U.S. District Court for the District of New Jersey.

Judiciary And Judicial Procedure — District Courts; Venue — Jurisdiction And Venue — Multidistrict Litigation Judiciary And Judicial Procedure — District Courts; Venue — Jurisdiction And Venue — Change Of Venue

The JPML ruled to centralize the federal litigation in the U.S. District Court of New Jersey in Trenton. It reasoned that the district is “a convenient and accessible forum,” located in “close proximity” to the state court actions, and because J&J is headquartered in New Jersey, represented a venue where the most “relevant evidence and witnesses” could be found.

1 Pursuant to the August 2, 2017 JPML Transfer Order, all cases in this litigation would be transferred to the District of New Jersey and assigned to the Honorable Claire C. Cecchi for coordinated or consolidated pretrial proceedings.

For the second time this year, a panel of federal judges is being asked to consolidate all federal lawsuits involving allegations that users suffered severe kidney damage from popular heartburn drugs, such as Nexium, Prilosec, Prevacid, Dexilant and Protonix.

December 8, 2016 — Federal judges have centralized nearly 100 lawsuits involving kidney damage, ketoacidosis, and other side effects of Invokana and Invokamet into a.

Given similar questions of fact and law raised in the various PPI cases, the U.S. Judicial Panel on Multidistrict Litigation (JPML) established consolidated pretrial proceedings in the federal court system in late July, centralizing all lawsuits before U.S. District Judge Claire C. Cecchi in the District of New Jersey to reduce duplicative discovery, avoid conflicting pretrial rulings and to.

The suit was filed in the U.S District Court for the District of New Jersey, Newark Division on behalf of a New Jersey couple. Like other PPIs, Nexium, “the purple pill”, is used to reduce the amount of acid produced by the stomach. It is used to treat acid reflux, heartburn, and other related conditions.

06.09.2017  · The Judicial Panel on Multidistrict Litigation (JPML) entered an Order consolidating the Proton Pump Inhibitor (PPI) multidistrict litigation (MDL) 2757 (Nexium, Prevacid, et. al) on August 2, 2017. The PPI MDL has been assigned to Judge Claire C. Cecchi, United States District Court of New Jersey.

Gerd Helmke Steckel, Gerd U. Regular Faculty. Assistant Professor. AY. 49,592.40. Helmke, Angela Largent. Associate Director of Admissio. FY. 53,497.60. Hotinger. Autogramme und Autographen – Uebersicht über Original-Unterschriften aus allen Bereichen –

On October 4, 2016, the Judicial Panel on Multidistrict Litigation (JPML) issued an order transferring federal cases alleging that women developed ovarian or uterine cancer following use of Johnson & Johnson’s talcum powder products (namely Johnson’s Baby Powder and Shower to Shower body powder) to U.S. District Judge Freda L. Wolfson in.

Jan. 18, 2017 – San Diego, CA — The number of Invokana lawsuits has been climbing steadily since the Judicial Panel on Multidistrict Litigation (JPML) consolidated federal cases in New Jersey last month.

The Judicial Panel on Multidistrict Litigation on Thursday said the Eastern District of Pennsylvania is the best place to consolidate lawsuits accusing Mylan.

Another argument for consolidation in New Jersey is that it is located near corporate headquarters. In court filings, it is claimed that 65 deaths have been linked to.

Leave a Reply

Your email address will not be published. Required fields are marked *